Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

ONPH

Oncology Pharma (CE) (ONPH)

Oncology Pharma Inc (CE)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:ONPH
DateTimeSourceHeadlineSymbolCompany
07/12/20227:36AMInvestorsHub NewsWireOncology Pharma Conducting Interviews and Presentations with Investors to Pursue Next Steps to Forward The Development Process of Nanoemulsion Drug Delivery SystemUSOTC:ONPHOncology Pharma Inc (CE)
06/29/20228:23AMInvestorsHub NewsWireOncology Pharma Conducting All The Preparations to Take Steps to Forward The Development Process of Nanoemulsion Drug Delivery SystemUSOTC:ONPHOncology Pharma Inc (CE)
06/08/20227:17AMInvestorsHub NewsWireOncology Pharma Announces: Initial Feasibility Study of the Nanoemulsion Drug Delivery System is Complete and Results Have Met the Threshold for Moving Forward To the Next Steps of DevelopmentUSOTC:ONPHOncology Pharma Inc (CE)
05/09/20227:48AMInvestorsHub NewsWireOncology Pharma Advances Progress on Multiple Fronts Including Advanced Attention to Connect2Trials' Commercial DevelopmentUSOTC:ONPHOncology Pharma Inc (CE)
04/13/20227:45AMInvestorsHub NewsWireOncology Pharma Completes Feasibility Phase of its Licensed Nanoemulsion Drug Delivery System to Treat CancerUSOTC:ONPHOncology Pharma Inc (CE)
03/02/20227:03AMInvestorsHub NewsWireOncology Pharma Reports on Progress with Ribera SolutionsUSOTC:ONPHOncology Pharma Inc (CE)
02/23/20227:00AMInvestorsHub NewsWireOncology Pharma Releases Further Feasibility Studies, Data and CapacitiesUSOTC:ONPHOncology Pharma Inc (CE)
02/17/20227:16AMInvestorsHub NewsWireOncology Pharma Expands on Feasibility Studies and DataUSOTC:ONPHOncology Pharma Inc (CE)
02/14/20227:11AMInvestorsHub NewsWireOncology Pharma, Inc. and Regen BioPharma, Inc. Announce Intent to Jointly Fast Track Development of Modified mRNA anti-Cancer VaccineUSOTC:ONPHOncology Pharma Inc (CE)
02/08/20227:30AMInvestorsHub NewsWireOncology Pharma Gives Update on Technology, Formulation and Data CreationUSOTC:ONPHOncology Pharma Inc (CE)
01/10/20227:15AMInvestorsHub NewsWireOncology Pharma's New Year UpdateUSOTC:ONPHOncology Pharma Inc (CE)
12/17/20217:11AMInvestorsHub NewsWireOncology Pharma Meeting Towards Future DevelopmentsUSOTC:ONPHOncology Pharma Inc (CE)
12/09/20217:04AMInvestorsHub NewsWireOncology Pharma Year End Review and OutlookUSOTC:ONPHOncology Pharma Inc (CE)
11/30/20217:02AMInvestorsHub NewsWireOncology Pharma Research and VisionUSOTC:ONPHOncology Pharma Inc (CE)
11/08/20217:00AMInvestorsHub NewsWireOncology Pharma Reveals Plans for Development of Lead Cancer Drug CandidateUSOTC:ONPHOncology Pharma Inc (CE)
10/28/202110:11AMInvestorsHub NewsWireOncology Pharma, Inc. Gives Update on Ongoing Work and ProgressUSOTC:ONPHOncology Pharma Inc (CE)
10/15/20217:12PMStockInvest.usHigh volatility in Oncology Pharma Inc. stock price on Friday which ended trading at $13.95USOTC:ONPHOncology Pharma Inc (CE)
10/15/20217:12PMStockInvest.usHigh volatility in Oncology Pharma Inc. stock price on Friday which ended trading at $13.95USOTC:ONPHOncology Pharma Inc (CE)
10/15/20217:12PMStockInvest.usHigh volatility in Oncology Pharma Inc. stock price on Friday which ended trading at $13.95USOTC:ONPHOncology Pharma Inc (CE)
10/15/20217:12PMStockInvest.usHigh volatility in Oncology Pharma Inc. stock price on Friday which ended trading at $13.95USOTC:ONPHOncology Pharma Inc (CE)
10/15/20219:51AMInvestorsHub NewsWireOncology Pharma, Inc. Has Engaged a PCAOB Audit Firm Looking Towards Moving the Company Towards a Senior ListingUSOTC:ONPHOncology Pharma Inc (CE)
10/12/20217:30AMInvestorsHub NewsWireOncology Pharma, Inc. Update on PCAOB Audit Selection Process and License AgreementUSOTC:ONPHOncology Pharma Inc (CE)
10/04/20217:09PMStockInvest.usBig movements in Oncology Pharma Inc. stock price on Monday moving 40.14% between high and lowUSOTC:ONPHOncology Pharma Inc (CE)
10/04/20217:09PMStockInvest.usBig movements in Oncology Pharma Inc. stock price on Monday moving 40.14% between high and lowUSOTC:ONPHOncology Pharma Inc (CE)
10/04/20217:09PMStockInvest.usBig movements in Oncology Pharma Inc. stock price on Monday moving 40.14% between high and lowUSOTC:ONPHOncology Pharma Inc (CE)
10/04/20217:09PMStockInvest.usBig movements in Oncology Pharma Inc. stock price on Monday moving 40.14% between high and lowUSOTC:ONPHOncology Pharma Inc (CE)
10/04/20217:09PMStockInvest.usBig movements in Oncology Pharma Inc. stock price on Monday moving 40.14% between high and lowUSOTC:ONPHOncology Pharma Inc (CE)
10/04/20217:09PMStockInvest.usBig movements in Oncology Pharma Inc. stock price on Monday moving 40.14% between high and lowUSOTC:ONPHOncology Pharma Inc (CE)
10/04/20217:09PMStockInvest.usBig movements in Oncology Pharma Inc. stock price on Monday moving 40.14% between high and lowUSOTC:ONPHOncology Pharma Inc (CE)
09/16/20217:08PMStockInvest.usHigh volatility in Oncology Pharma Inc. stock price on Thursday which ended trading at $11.35USOTC:ONPHOncology Pharma Inc (CE)
 Showing the most relevant articles for your search:USOTC:ONPH